Cardiopulmonary effects of romifidine and detomidine used as premedicants for ketamine/halothane anaesthesia in ponies.

This research investigates the cardiovascular effects of romifidine and detomidine, substances often used as premedicants for ketamine/halothane anaesthesia in ponies. Various parameters were studied during anaesthesia, including arterial blood pressure, cardiac index, and more.

Research Context

• The research was designed to understand the potential cardiopulmonary effects of two alpha-2 agonists, romifidine and detomidine, when used as premedicants before administering ketamine/halothane anaesthesia in ponies.
• Romifidine and detomidine are commonly used in veterinary medicine as pre-anesthetic drugs because of their relaxing effects, but their impacts on the cardiopulmonary system during anesthesia have not been thoroughly investigated.

Research Design and Methods

• The researchers adopted a blinded crossover design, a robust methodology that eliminates potential bias and improves the validity of the results.
• The ponies were first administered acepromazine, followed by either romifidine or detomidine. The anaesthesia was then induced with ketamine and maintained with halothane (in oxygen) for a period of three hours.

Key Research Findings

• Among the various measured parameters, during anaesthesia, arterial blood pressure, cardiac index, PaO2, and PmvO2 decreased. Systemic vascular resistance and PaCO2 increased instead.
• The cardiac indices for R80, R120, and D20 indicated a decrease in values at 180 minutes compared to 30 minutes. However, all three groups demonstrated similar cardiovascular effects.
• Significant observation was that PaO2 (partial pressure of oxygen in arterial blood) was found to be significantly lower with R120, potentially indicating a greater risk of oxygen desaturation during anaesthesia.
• The quality of anaesthesia was found to be similar in all three groups, thus indicating that, despite their different cardiopulmonary effects, both romifidine and detomidine seem equally effective as premedicants.

Conclusion and Implications

• The research concluded that while both romifidine and detomidine have similar cardiovascular effects, romifidine at higher concentration (R120) could potentially lead to lower oxygen levels during anaesthesia. This information is crucial in veterinary medicine as it informs clinicians about potentially adverse effects and can guide their decisions regarding anaesthetic regimes.
• Further studies are needed to evaluate the long-term impacts of these premedicants on the cardiopulmonary health of ponies and to determine the optimal dosing to balance efficacy and safety.